13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 101 holding rows worth $4,684,196,240.
- Accession
- 0000950159-23-000249
- Filer
- CIK 1009258
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 101 entries on the cover page, a total value of $4,684,196,240 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,684,196,241 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 19,991,024 | $843,021,482 | dollars as filed | |
| GLAUKOS CORP | 377322AB8 | BOND | 271,452,000 | $412,733,808 | dollars as filed | principal |
| VIATRIS INC COM | 92556V106 | Stock | 17,703,484 | $176,680,770 | dollars as filed | |
| AMEDISYS INC | 023436108 | COM | 1,794,000 | $164,043,360 | dollars as filed | |
| NATERA INC | 632307AB0 | BOND | 101,042,000 | $146,914,664 | dollars as filed | principal |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 11,094,914 | $135,025,103 | dollars as filed | |
| IONIS PHARMACEUTICALS INC | 462222AD2 | NOTE 4/0 | 127,800,000 | $121,005,130 | dollars as filed | principal |
| TABULA RASA HEALTHCARE INC | 873379AA9 | NOTE | 144,516,000 | $119,962,154 | dollars as filed | principal |
| BROOKDALE SR LIVING INC | 112463AC8 | NOTE 2.000%10/1 | 145,955,000 | $114,840,751 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,209,714 | $114,076,030 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 8,192,000 | $110,100,480 | dollars as filed | |
| ACCOLADE INC | 00437EAB8 | NOTE 0.500% 4/0 | 122,598,000 | $102,113,958 | dollars as filed | principal |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 103,200,000 | $98,192,736 | dollars as filed | principal |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 6,707,026 | $94,434,926 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAC2 | NOTE 3.500% 2/1 | 98,354,000 | $94,044,128 | dollars as filed | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 1,349,000 | $90,990,050 | dollars as filed | |
| ACCENDRA HEALTH INC | 690732102 | COM | 4,745,000 | $90,344,800 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 3,031,938 | $79,830,928 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 11,077,927 | $74,222,111 | dollars as filed | |
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 89,036,000 | $63,919,479 | dollars as filed | principal |
| HILLEVAX INC | 43157M102 | COM | 3,329,231 | $57,229,481 | dollars as filed | |
| ENHABIT INC | 29332G102 | COM | 4,809,803 | $55,312,735 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 70,204,000 | $54,773,020 | dollars as filed | principal |
| BROOKDALE SR LIVING INC | 112463104 | COM | 12,679,651 | $53,508,127 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,268,628 | $53,312,758 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 16,941,357 | $53,026,447 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 15,861,090 | $49,327,990 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,751,496 | $46,852,518 | dollars as filed | |
| LIVONGO HEALTH INC | 539183AA1 | NOTE 0.875% 6/0 | 50,000,000 | $45,170,000 | dollars as filed | principal |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 1,253,999 | $44,893,164 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,579,349 | $41,410,531 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,366,345 | $39,857,525 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,132,229 | $36,786,120 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,238,000 | $34,258,040 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366JAD3 | NOTE 1.500% 9/1 | 32,000,000 | $33,000,928 | dollars as filed | principal |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,933,137 | $30,481,812 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,340,118 | $30,210,923 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 2,535,723 | $30,149,746 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 3,059,000 | $28,662,830 | dollars as filed | |
| HEALTH CATALYST INC | 42225TAB3 | BOND | 30,000,000 | $28,615,470 | dollars as filed | principal |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 313,289 | $28,540,628 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 627,813 | $26,098,186 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 2,077,893 | $22,981,497 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,050,198 | $22,652,771 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 870,000 | $22,019,700 | dollars as filed | |
| XERIS PHARMACEUTICALS INC | 98422LAA5 | NOTE 5.000% 7/1 | 18,000,000 | $21,409,596 | dollars as filed | principal |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 1,189,648 | $21,389,871 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 617,000 | $20,237,600 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 2,052,010 | $19,288,894 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 430,000 | $19,092,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,125,000 | $18,236,250 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 594,989 | $17,558,125 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,898,743 | $16,614,001 | dollars as filed | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 1,600,000 | $16,416,000 | dollars as filed | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 17,211,000 | $15,265,193 | dollars as filed | principal |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,269,992 | $15,163,704 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 837,000 | $14,270,850 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,064,285 | $13,952,776 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 658,546 | $13,895,321 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,354,974 | $13,658,138 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 650,000 | $13,585,000 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 2,823,000 | $13,183,410 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 1,400,352 | $13,065,284 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 885,314 | $12,969,850 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 613,000 | $12,468,420 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 650,000 | $11,745,500 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,538,461 | $11,446,150 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 225,000 | $11,355,750 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 1,842,000 | $10,591,500 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 5,854,860 | $10,538,748 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,885,400 | $9,492,966 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 656,000 | $9,393,920 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,322,000 | $9,306,880 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 1,800,000 | $9,090,000 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 1,253,895 | $7,473,214 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $6,341,704 | dollars as filed | |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 6,500,000 | $6,051,468 | dollars as filed | principal |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 777,525 | $5,473,776 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 6,450,871 | $5,354,223 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 455,262 | $3,646,649 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 869,565 | $3,504,347 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279119 | *W EXP 09/30/202 | 1,000,000 | $2,480,000 | dollars as filed | |
| ACUTUS MED INC | 005111109 | COM | 2,660,808 | $2,362,798 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,381,416 | $2,099,752 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $2,055,374 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $1,848,701 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 316,169 | $1,647,240 | dollars as filed | |
| QUANTUM SI INC | 74765K105 | COM CL A | 797,500 | $1,427,525 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 265,657 | $1,065,285 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 672,000 | $259,392 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 836,626 | $205,057 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $193,925 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $172,700 | dollars as filed | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $76,700 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $34,875 | dollars as filed | |
| SOMALOGIC INC | 83444k113 | WT | 120,000 | $30,000 | dollars as filed | |
| SIENTRA INC | 82621J204 | COMMON | 10,000 | $29,300 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $27,567 | dollars as filed | |
| MEDTECH ACQUISITION CORP | 58507N113 | *W EXP 12/22/202 | 333,333 | $13,967 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $9,200 | dollars as filed | |
| MEDTECH ACQUISITION CORP | 58507N204 | UNIT 12/18/2025 | 1 | $10 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-23-000249 | this filing | 2023-08-14 | acceptance time not in the bulk data set |